Tumor Immunology Program (D030), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Cancer Lett. 2013 May 28;332(2):304-12. doi: 10.1016/j.canlet.2010.07.015. Epub 2010 Aug 3.
The traditional Chinese medicine (TCM) uses a combination of different natural products based on practical experiences. To better understand the therapeutic functions of TCM, large efforts have been made to identify the principle constituents of TCM and to unravel the molecular mechanisms behind the efficacy observed. This review aims to summarize research results obtained from the most intensively studied TCM phytochemical compounds namely the alkaloids Berberine, Evodiamine; anthraquinones Emodin, Aloe-emodin, Rhein; the terpenoids Artemisinin, Celastrol, Triptolide; the flavones Apigenin, Chrysin, Wogonin, Baicalein; and the cyclopenta[b]benzofuran derivatives Rocaglamide. Most of them have been originally identified as anti-inflammatory and anti-viral reagents and are now known to also possess anti-tumor activities by targeting the apoptosis pathways in cancer. This review also intends to give an overview of the mechanisms of action identified so far. These breakthrough findings may have important implications for targeted-cancer therapy and for modernization of TCM.
中药(TCM)使用基于实践经验的不同天然产物的组合。为了更好地了解 TCM 的治疗功能,人们做出了巨大的努力来识别 TCM 的主要成分,并揭示观察到的功效背后的分子机制。本综述旨在总结从研究最多的 TCM 植物化学化合物中获得的研究结果,即生物碱小檗碱、吴茱萸碱;蒽醌大黄素、芦荟大黄素、大黄酸;萜烯青蒿素、雷公藤红素、雷公藤内酯;黄酮类芹菜素、白杨素、高良姜素、黄芩素;和环戊[b]苯并呋喃衍生物罗卡酰胺。它们中的大多数最初被鉴定为抗炎和抗病毒试剂,现在已知通过靶向癌症中的细胞凋亡途径也具有抗肿瘤活性。本综述还旨在概述迄今为止确定的作用机制。这些突破性的发现可能对癌症的靶向治疗和 TCM 的现代化具有重要意义。